During the past decade, UC Health Clinical Trials Office conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UC Health Clinical Trials Office" #1 sponsor was "Celgene" with 5 trials, followed by "EMD Serono Research & Development Institute, Inc." with 5 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "AlphaVax, Inc." with 1 trials sponsored and "Calithera Biosciences, Inc" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC Health Clinical Trials Office" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "UC Health Clinical Trials Office" are "Crohn Disease" (2 trials), "Solid Tumors" (2 trials), "Ulcerative Colitis" (2 trials), "Acute Myelogenous Leukemia" (1 trials) and "Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification" (1 trials). Many other conditions were trialed in "UC Health Clinical Trials Office" in a lesser frequency.

Most popular intervention types in "UC Health Clinical Trials Office" are "Drug" (18 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "RPC1063" (3 trials), "Avelumab" (2 trials), "GED-0301" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "UC Health Clinical Trials Office" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UC Health Clinical Trials Office". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in UC Health Clinical Trials Office, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UC Health Clinical Trials Office, 6 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".